there is an interesting piece by my colleague in london who talk to us strategist at mizuho, and he is saying the five year yield is keeping him up at night. he thinks the way at shot up, 75 basis points yesterday, that implies more tightening in the market, and if you're the fed, you don't want more tightening if you are relying on near zero rates. romaine: you talked about the five year yield, the line in the sand around 75. take the spotlight off jerome powell and shined it on janet yellen in the treasury. some of their decisions to stop selling on the short end of the curve and other maturities, i'm curious as to whether the treasury could right size things, at least until jerome powell in the company figure out what they want to do. >> yeah, you know, it is not a great time to be pulling back on those sales. i feel like the treasury and the fed is in a lose-lose. it is too big. i think everyone thought that would come down when the stimulus bills passed, and they have not come down. there is no reason to be sitting on $1.6 trillion in their account at the fed. however, there is so

mizuho morrison, an emergency physician in southern california, she's also the senior director of medical education at hippo education, doctor, good to see you. >> so good to see you, thank you so much for having me back. >> all right, so how encouraged are you about this pending authorization for this johnson & johnson vaccine. >> the medical board is very encouraged, we have a third very strong legitimate vaccine as an option and certainly will increase our effort to combat this virus. >> and then there are some officials who are concerned that some americans may view the johnson & johnson vaccine as, you know, second class because its efficacy rate is below 90%, unlike the pfizer and moderna. how should people be accepting and thinking and feeling about johnson & johnson? >> you know, you have to look at the numbers sort of relatively. meaning their study was done later before pfizer and moderna. therefore their numbers are going to be a little bit off. really, to know which one is most, you know, superior, what you have to do is have a head to head comparative trial, which we've not d

square, the payment processer fell 3% in today's session despite a price target boost the $380 mizuholued and the cash could clear $30 billion in gross profits by 2013. let's bring in mike to check in what traders had to say about this call. mike >> yeah, so this is a name that is seeing bullish activity, calls have outpaced puts for the last 20 days on average by about 2 to 1 and that continued today and the most active options we saw were the 300 strike calls that expire at the end of this week over 8,000 of those were trading for about $3.70. that would represent an upside move of about 13% or more just to break even. right now the options market is actually only implying a move of a little over 9% and over the last eight quarters only averaged about 8%. so buyers of those calls are going to need to see something pretty extraordinary to see profits by the end of this week. >> i thought the price target increase was interesting, dan, the analyst we've had him on the show a couple times, a part of this call was the increase interest in bitcoin as it ramps to new highs and the influx

mizuho among those reporting. that stock gaining ground. nintendo on the back of their earnings. we are seeing the nikkei 225 voting 28,000 points with that softer yen providing a boost, crossing that 105 level for the first time since november overnight today, we are seeing the dollar under pressure and as we wait on the potential extension of a state of emergency in japan, gdp generators wanting to see what this may mean. checking on what is going on in south korea, we will see if there's any lines regarding a fourth line of cash handout. the won under pressure this morning we have the latest inflation data to assess as well. dpi rose slightly. the price target was boosted to $1200 and keeping an eye on what any developments they had around shortselling. they warned of market volatility amid calls to permanently ban the practice in south korea. let's look at what's going on in sydney. aussie shares are rising while bonds are under pressure for a third session ahead of the rba decision. u.s. futures, we are seeing them gain some ground whi